Roche diabetes app accused of patent infringement
US-based Encoditech yesterday accused a Roche subsidiary of infringing a patent related to wireless communication.
The claim was filed against Roche Diabetes Care at the US District Court for the District of Delaware.
According to Encoditech, Roche’s blood glucose monitoring app, Accu-Chek, infringes the company’s “Wireless communications approach” patent (US number 6,321,095).
Encoditech’s patent protects technology relating to a mobile station that provides direct wireless communications with another mobile station (such as a mobile phone) using a radio frequency.
The technology was created to improve wireless communications without requiring a physical infrastructure of digital cellular telephone systems.
Encoditech alleged that Roche has infringed the patent’s claim 7, which cites a “wireless communication system”, by providing the Accu-Chek app.
For example, Roche’s app monitors blood pressure, heart rate and irregular heartbeats by combining with an electronic device, such as a phone tablet, claimed Encoditech.
Accu-Chek is a device that carries outs these tests and communicates the results to the user’s mobile phone app.
Encoditech added that Roche has intended that its customers use the program in a way that infringes the company’s ‘095 patent.
“Even where performance of the steps required to infringe at least claim 7 of the ‘095 patent is accomplished by Roche and Roche’s customer jointly, Roche’s actions have solely caused all of the steps to be performed,” alleged Encoditech.
The company is seeking damages, a permanent injunction against Roche and a jury trial.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk